Cresco Labs continued a four day positive streak, up 1.79% to $1.71.

Yesterday at a glance: after dipping down to $1.56, Cresco Labs regained earlier losses, closing higher at $1.71.

United States EIA Short-Term Energy Outlook is next today at 16:00 UTC.

Chart analysis suggests Cresco Labs Inc. could be slowing down soon as it approaches resistance at $1.76. Of course, crossing it might suggest further gains are ahead. Trend-focused traders would be interested to note that the Commodity Channel Index (CCI) indicator is above +100, meaning the market price is unusually high compared to the rolling average. According to asset volatility analysis, Bollinger Band® analysis indicates that current price action is approaching the upper band at $1.7, thereby suggesting that Cresco Labs is becoming overvalued.

Overall, while Cresco Labs has been on an uptrend, technical indicators suggest that it has no obvious direction for the immediate future.

This rally in Cresco Labs's share price coincided with other health care stocks as Novo Nordisk gained 3.19%, as it traded at $168.44. Stryker added 1.25% to its value, and traded at $288.27.

While Cresco Labs was bullish yesterday, the following health care stocks underperformed: Sanofi went down 1.51%, closed at $55.77.

Furthermore, the market is looking at United States Crude Oil Inventories expected to decline to -1.6 million while its preceding data was -1.28 million, data will be available tomorrow at 14:30 UTC.

The market is looking forward to the release of new data: United States Consumer Price Index is expected tomorrow at 12:30 UTC. United States Core Consumer Prices figure is projected at 0.4%. It previously stood at 0.4%; data will be released tomorrow at 12:30 UTC.

Having set a significant low of $1.39 18 days ago, the medical marijuana company is trading 20.86% higher.